Local Inventor Honored for Developing World s First Antihistamine
George Rieveschl, PhD, while a chemical engineering professor at the University of Cincinnati (UC), invented the drug Benadryl, the worlds first effective antihistamine.
Dr. Rieveschl will be recognized in conjunction with the 60th anniversary of Benadryl, commonly used to treat allergy symptoms such as hay fever, rashes and hives. The reception will be held from 5:30 to 7 p.m. at the Queen City Club,
Dr. Rieveschl found that his two-part compound, originally tested to improve muscle-relaxing medications, dramatically blocked histamine, a chemical released in the body that narrows air passages in the lungs and causes inflammation.
This surprising breakthrough led to Benadryl becoming the first FDA-approved prescription antihistamine in 1946. First produced by Parke, Davis and Company, the drug is now distributed over-the-counter by the Parke-Davis division of Pfizer, Inc.
A 1937 alumnus of UC, Dr. Rieveschl spent 26 years working in the chemical industry as both a scientist and a consultant before returning to UC in 1970. He currently is a professor emeritus of environmental engineering.
Jane Henney, MD, senior vice president and provost for health affairs at the UC Academic Health Center, and Karen Gould, PhD, dean of the
Invented by UC scientist George Rieverschl, PhD, Benadryl is the world's first effective antihistamine.
Tags
Related Stories
University of Cincinnati College of Medicine celebrates Class of 2026 at Honors Day
April 21, 2026
The UC College of Medicine celebrates the Class of 2026 at Honors Day. With a 100% residency match rate, 177 new MD, MD-PhD and MD-MPH graduates prepare for top-tier training nationwide.
Five UC College of Medicine faculty honored at 2026 All-University Faculty Awards celebration
April 21, 2026
Celebrate the five University of Cincinnati College of Medicine faculty members honored for extraordinary contributions to research, teaching and service in 2026.
Mini-brain reveals how concussions trigger neurodegenerative cascades
April 21, 2026
Medical XPress highlights biomedical engineering research at the University of Cincinnati that used a mini-brain model to study the cascade of neurodegenerative effects caused by blunt-force trauma associated with concussions.